Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2024 May 13;12(5):e004113corr1. doi: 10.1136/jitc-2021-004113corr1

Correction: Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway

PMCID: PMC11097841  PMID: 38740466

Zhuo Y, Li S, Hu W, et al. Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway J ImmunoTher Cancer 2022;10:e004113. doi: 10.1136/jitc-2021-004113

This article has been corrected after publication to remove Dejia Liu from the author list. This author contacted BMJ after publication to state that they should not be listed as an author on this work because they did not read the manuscript, contribute to its contents or approve the submission. The journal corresponded with the institution and other authors regarding this, and concluded that this individual should be removed from the author list as they did not fulfil BMJ’s authorship criteria.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES